Midazolam (Dormicum) as an intravenous induction agent, a clinical experience at Muhimbili Medical Center

Simple item page
dc.contributor.authorLugazia, Edwin Rwebugisa
dc.date.accessioned2019-10-19T09:41:54Z
dc.date.accessioned2020-01-08T10:06:10Z
dc.date.available2019-10-19T09:41:54Z
dc.date.available2020-01-08T10:06:10Z
dc.date.issued2000
dc.descriptionAvailable in print form, East Africana Collection, Dr. Wilbert Chagula Library, Class mark (THS EAF RA975.5.A5L84)en_US
dc.description.abstractMidazolam a new intravenous induction agent of the benzodiazepine class was studied in 120 healthy unpremedicated patients. These patients were undergoing short diagnostic and therapeutic procedures lasting less than one hour. The mean duration of Anaesthesia was 22.63minutes. Rapid smooth induction of anaesthesia was attained with an induction dose of 0.3mg/kg. with the mean induction time of 67.82 seconds. Characteristics of concern were transient apnoea 25.84%, incidence of side effects which was found to be low and changes in the systolic and diastolic blood pressure which were found to be significant, but well torelated by these healthy patients. Haemoglobin levels as well as serum albumin levels were not shown to have any effect on the induction characteristics of midazolam. Induction was also associated with short recovery and orientation time. These were found to have a positive correlation to the duration of anaesthesia.en_US
dc.identifier.citationLugazia, E. R. (2000) Midazolam (Dormicum) as an intravenous induction agent, a clinical experience at Muhimbili Medical Center, Master dissertation,University of Dar es Salaam. Dar es Salaamen_US
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/6124
dc.language.isoenen_US
dc.publisherUniversity of Dar es Salaamen_US
dc.subjectMidazdomen_US
dc.titleMidazolam (Dormicum) as an intravenous induction agent, a clinical experience at Muhimbili Medical Centeren_US
dc.typeThesisen_US

Files

Collections

Masters Dissertations